Cargando…
Macrophage Death as a Pharmacological Target in Atherosclerosis
Atherosclerosis is a chronic inflammatory disorder characterized by the gradual build-up of plaques within the vessel wall of middle-sized and large arteries. Over the past decades, treatment of atherosclerosis mainly focused on lowering lipid levels, which can be accomplished by the use of statins....
Autores principales: | Martinet, Wim, Coornaert, Isabelle, Puylaert, Pauline, De Meyer, Guido R. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458279/ https://www.ncbi.nlm.nih.gov/pubmed/31019462 http://dx.doi.org/10.3389/fphar.2019.00306 |
Ejemplares similares
-
The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
por: Puylaert, Pauline, et al.
Publicado: (2022) -
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022) -
High Pulsatile Load Decreases Arterial Stiffness: An ex vivo Study
por: Neutel, Cédric H. G., et al.
Publicado: (2021) -
Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
por: Flynn, Michelle C., et al.
Publicado: (2019) -
Defective Autophagy in Atherosclerosis: To Die or to Senesce?
por: Grootaert, Mandy O. J., et al.
Publicado: (2018)